Novel schizophrenia therapy filed for FDA approval

Nat Rev Drug Discov. 2023 Nov;22(11):862. doi: 10.1038/d41573-023-00164-z.
No abstract available

Publication types

  • News

MeSH terms

  • Drug Approval
  • Humans
  • Schizophrenia* / drug therapy
  • United States
  • United States Food and Drug Administration